AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Frey-Met G2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Algen Healthcare Limited

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Frey-Met G2 Tablet SR

GlucoTwin G2 Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer GlucoTwin G2 ER with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as discontinuation without medical consultation can elevate glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Prompt glucose intake (e.g., sugary foods, fruit juice) is essential. Alcohol should be avoided due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain may also occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Uses of Frey-Met G2 Tablet SR

Managing type 2 diabetes

Major Benefits of Frey-Met G2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Frey-Met G2 Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. This medication should be taken with a meal.

Common Side effects of Frey-Met G2 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Frey-Met G2 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Frey-Met G2 Tablet SR whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

How Frey-Met G2 Tablet SR works:

Frey-Met G2 SR tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with Frey-Met G2 Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Frey-Met G2 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Frey-Met G2 tablets are contraindicated for breastfeeding mothers. Evidence indicates a potential risk of infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when prescribing Frey-Met G2 Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is recommended. Frey-Met G2 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Frey-Met G2 SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Frey-Met G2 Tablet SR :

Should you forget a dose of Frey-Met G2 Tablet SR, take it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.

Facts to Know About Frey-Met G2 Tablet SR

LabelValue
Addictive None.
Medication Classification Medication for diabetes

FAQs on Frey-Met G2 Tablet SR

Store the medication in its original, tightly sealed container, following the storage guidelines provided on the packaging. Discard any leftover medication. Ensure the medicine remains inaccessible to children, pets, and others.
Indeed, Frey-Met G2 Tablet SR use may result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. This is also termed MALA (Metformin-associated lactic acidosis). While infrequent, this adverse reaction to metformin poses a significant risk for individuals with pre-existing kidney impairment, the elderly, or those who consume substantial alcohol. Lactic acidosis symptoms can manifest as muscular discomfort or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal pain, or bradycardia. Should these symptoms appear, discontinue Frey-Met G2 Tablet SR and seek immediate medical attention.
The sustained-release Frey-Met G2 Tablet combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication enhances glycemic control when used in conjunction with a suitable diet and physical activity. Glimepiride stimulates insulin secretion from the pancreas, thereby reducing blood glucose. Metformin concurrently decreases hepatic glucose production and increases insulin sensitivity. This dual-agent therapy is unsuitable for treating type 1 diabetes mellitus.
Frey-Met G2 Tablet SR may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged treatment may result in vitamin B12 deficiency.
Prolonged Frey-Met G2 Tablet SR use can indeed lead to Vitamin B12 deficiency by hindering its gastrointestinal absorption. This deficiency, if left unaddressed, may result in anemia, neurological complications including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and gait instability. Consequently, supplemental Vitamin B12 intake, at least annually, is recommended by some experts to mitigate these risks.
Indeed, Frey-Met G2 Tablet SR can induce hypoglycemia. This low blood sugar condition manifests as nausea, headache, irritability, hunger pangs, sweating, dizziness, tachycardia, and feelings of anxiety or tremors. The risk increases with missed or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying readily available glucose, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Frey-Met G2 Tablet SR and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia). Alcohol use also elevates the likelihood of lactic acidosis.
Frey-Met G2 Tablet SR
57
MRP 70
18% off